Ignite Creation Date:
2024-05-05 @ 11:48 AM
Last Modification Date:
2024-10-26 @ 9:13 AM
Study NCT ID:
NCT00137774
Status:
COMPLETED
Last Update Posted:
2013-04-09
First Post:
2005-08-26
Brief Title:
Bevacizumab in Combination With Temozolomide in Patients With Neuroendocrine Tumors
Sponsor:
Organization:
Dana-Farber Cancer Institute